Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) Antibody
819€ (1 ml)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Name
Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) Antibody
Category
Primary Antibodies
Provider
Abbexa
Reference
abx171474
Tested Applications
WB, IHC, IF/ICC
Description
This product is currently in development. The lead time for this product may be several months. Please contact us at
Documentos del producto
Instrucciones
Data sheet
Especificaciones del producto
| Category | Primary Antibodies |
| Immunogen Target | Target: Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) |
| Host | Mouse |
| Reactivity | Human |
| Recommended Dilution | WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Monoclonal |
| Conjugation | Unconjugated |
| Purification | Purified by Protein A and Protein G affinity chromatography. |
| Size 1 | 1 ml |
| Form | Liquid |
| Tested Applications | WB, IHC, IF/ICC |
| Buffer | 0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol. |
| Availability | Please enquire. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Alias | BCAR1, CAS, CAS1, CASS1, CRKAS, P130Cas, Cas family scaffolding protein, Cas family scaffold protein, BCAR1 scaffold protein, Cas family member |
| Background | Antibody anti-BCAR1 |
| Status | RUO |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
Background
BCAR1, also known as the Breast Cancer Anti-Estrogen Resistance 1 protein, is an important protein involved in the development of resistance to anti-estrogen therapies, such as tamoxifen, used in the treatment of estrogen receptor-positive breast cancer. BCAR1 plays a crucial role in cell signaling pathways that regulate cell survival, proliferation, and resistance to apoptosis. It is often upregulated in breast cancer cells that become resistant to estrogen receptor-targeted therapies. The protein interacts with several other signaling molecules involved in the regulation of cell motility and survival, contributing to the metastatic potential of breast cancer cells. Understanding BCAR1’s role in therapy resistance has significant implications for developing alternative therapeutic strategies for patients with estrogen receptor-positive breast cancer who develop resistance to current treatments.
Productos relacionados
Breast Cancer Anti-Estrogen Resistance Protein 1 (BCAR1) Antibody
Breast Cancer Anti-Estrogen Resistance Protein 1 (BCAR1) Antibody is a Rabbit Polyclonal antibody for the detection of B…
Ver producto
Breast Cancer Anti-Estrogen Resistance Protein 1 Phospho-Tyr410 (BCAR1 pY410) Antibody
Rabbit polyclonal antibody against p130 Cas protein. Immunogen region is Internal. Specificity is as follows for the rea…
Ver producto
Breast Cancer Anti-Estrogen Resistance Protein 1 (Bcar1) Antibody
Docking protein which plays a central coordinating role for tyrosine kinase-based signaling related to cell adhesion. Im…
Ver producto